Hjem › Hjertesvikt › South Carolina › Charleston
Kliniske studier for Hjertesvikt i Charleston, SC
18 studier for Hjertesvikt søker deltakere på steder i og rundt Charleston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
ELEVATE-HFpEF Clinical Study
Rekrutterer
- Medical University of South Carolina (MUSC), Charleston
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
RekruttererFase 3
- Research Site, Charleston
- Research Site, Charleston
A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
RekruttererFase 1
- Medical University of South Carolina, Charleston
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
RekruttererFase 3
- Medical University of South Carolina - Gazes Research Institute, Charleston
Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
Rekrutterer
- Medical University of South Carolina, Charleston
Alleviant ALLAY-HFrEF Study
Rekrutterer
- Roper St. Francis Healthcare, Charleston
- Medical University of South Carolina, Charleston
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RekruttererFase 3
- Charleston, SC Investigative Site 10056, Charleston
The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
RekruttererObservasjonsstudie
- MUSC, Charleston
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Rekrutterer
- Medical University of South Carolina, Charleston
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
RekruttererFase 2
- Local Institution - 142, Charleston
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
RekruttererFase 3
- Tenax Investigational Site, Charleston
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RekruttererFase 3
- Med. Uni. of SC Ashley River T, Charleston
Alleviant ALLAY-HF Study
Rekrutterer
- Medical University of South Carolina, Charleston
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
RekruttererObservasjonsstudie
- Medical University of South Carolina, Charleston
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Rekrutterer
- Medical University of South Carolina (MUSC), Charleston
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Rekrutterer
- Medical University of South Carolina, Charleston
Left vs Left Randomized Clinical Trial
Rekrutterer
- Medical University of South Carolina (MUSC), Charleston
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
RekruttererObservasjonsstudie
- Medical University of South Carolina, Charleston
Hjertesvikt-studier i andre byer
- New York City, NY51 studier
- Boston, MA44 studier
- Dallas, TX42 studier
- Houston, TX36 studier
- Cleveland, OH33 studier
- Chicago, IL31 studier
- Philadelphia, PA31 studier
- San Francisco, CA29 studier
- Durham, NC26 studier
- St. Louis, MO26 studier
- Atlanta, GA25 studier
- Kansas City, MO25 studier
Andre studier i Charleston
- Depresjon19 studier
- Slag18 studier
- Ikke-småcellet lungekreft16 studier
- Posttraumatisk stresslidelse16 studier
- Kardiovaskulær sykdom15 studier
- Prostatakreft15 studier
- Kreft (alle typer)14 studier
- Plateepitelcancer i hode og hals14 studier
- Parkinsons sykdom13 studier
- Interstitielle lungesykdommer13 studier
- Brystkreft12 studier
- Lungekreft11 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.